MAPT and Alzheimer disease: This review surveys the utility of tau PET as a tool for staging disease progression, supporting differential diagnoses, and determining prognoses determination and projects the scope of tau PET’s potential utility in clinical trials and practice as progress is made toward effective therapeutic interventions for AD.